https://www.selleckchem.com/Bcl-2.html
Adrenocortical carcinoma while rare, often presents with advanced metastatic disease carrying a 5-year survival of 15%. Despite adrenocortical carcinoma tumors having high avidity for cholesterol, the role of lipids in adrenocortical carcinoma has not been well described. Therefore, we performed an integrated bioinformatic analysis to identify novel lipid biomarkers correlating with poor survival that may help identify adrenocortical carcinoma tumor progression or therapy resistance. A meta-analysis of collated adrenocortical carcinoma studies
Like
Comment
Share
